The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review Yu-Lin LinRu MaYan Li Review – Cancer Research Open access 22 July 2020 Pages: 2179 - 2188
Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR) Yao YeLin PengHelene H. Heidegger Original Article – Cancer Research Open access 01 June 2020 Pages: 2189 - 2203
Cholecystokinin type 2 receptor in colorectal cancer: diagnostic and therapeutic target Jiang ChangZeng-Shan LiuPan Hu Original Article – Cancer Research 02 June 2020 Pages: 2205 - 2217
The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation Alan Cheuk Keong YawElaine Wan Ling ChanChun Wai Mai Original Article – Cancer Research 07 June 2020 Pages: 2219 - 2229
Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion Jun XieXian ZhangChong Li Original Article – Cancer Research 12 June 2020 Pages: 2231 - 2239
Bone marrow adipocytes enhance osteolytic bone destruction by activating 1q21.3(S100A7/8/9-IL6R)-TLR4 pathway in lung cancer Guojing LuoMengjia TangXijie Yu Original Article – Cancer Research 03 June 2020 Pages: 2241 - 2253
Targeting glycolysis with 2-deoxy-d-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors Adrian Georg SimonLaura Kristin EsserMarieta Ioana Toma Original Article – Cancer Research 12 June 2020 Pages: 2255 - 2265
Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma Davide FranceschiniLuca CozziMarta Scorsetti Original Article – Cancer Research 08 June 2020 Pages: 2267 - 2276
Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing Xiaoyun ZhouXiaohui XuYushang Cui Original Article – Cancer Research 22 June 2020 Pages: 2277 - 2287
Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity Ciro FranzeseMarco Lorenzo BonuMarta Scorsetti Original Article – Cancer Research 10 June 2020 Pages: 2289 - 2297
Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma Jie LiuXiao YangDong Wang Original Article – Cancer Research Open access 18 June 2020 Pages: 2299 - 2310
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Dario ZeriniBarbara Alicja Jereczek-FossaThe Italian Association of Radiotherapy, Clinical Oncology (AIRO) Original Article – Cancer Research 24 June 2020 Pages: 2311 - 2317
Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma Florian GebauerMax KrämerAlexander Quaas Original Article – Cancer Research Open access 26 June 2020 Pages: 2319 - 2327
Non-small cell lung cancer patients with ex19del or exon 21 L858R mutation: distinct mechanisms, different efficacies to treatments W.-Q. LiJ.-W. Cui Review – Clinical Oncology 28 June 2020 Pages: 2329 - 2338
Artificial intelligence in gastric cancer: a systematic review Peng JinXiaoyan JiYantao Tian Review – Clinical Oncology 01 July 2020 Pages: 2339 - 2350
Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases Luca NicosiaFrancesco CucciaFilippo Alongi Original Article – Clinical Oncology 30 April 2020 Pages: 2351 - 2358
Targeted deep sequencing helps distinguish independent primary tumors from intrapulmonary metastasis for lung cancer diagnosis Jixian LiuGuangxian MaoDa Wu Original Article – Clinical Oncology 24 April 2020 Pages: 2359 - 2367
Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China Jian ZangMan XuMei Shi Original Article – Clinical Oncology 03 May 2020 Pages: 2369 - 2378
Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes Rosario MazzolaVanessa FigliaFilippo Alongi Original Article – Clinical Oncology 05 May 2020 Pages: 2379 - 2397
Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastases Sang-A KimJi-Won KimKeun-Wook Lee Original Article – Clinical Oncology 01 May 2020 Pages: 2399 - 2410
Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy Yang ZhangChaoqiang DengHaiquan Chen Original Article – Clinical Oncology 30 April 2020 Pages: 2411 - 2417
Recommendations on complementary and alternative medicine within S3 guidelines in oncology: systematic quality assessment of underlying methodology Sabine KutschanMaren FreudingJutta Huebner Original Article – Clinical Oncology Open access 11 May 2020 Pages: 2419 - 2425
Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes Yuxin MuXuezhi HaoJunling Li Original Article – Clinical Oncology Open access 08 May 2020 Pages: 2427 - 2433
MYC/BCL2/BCL6 triple hit lymphoma of the pericardium: a case report and review of the literature A. EfstathopoulouM. GhielminiE . Zucca Letter to the Editor 06 February 2020 Pages: 2435 - 2438